FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

17436911000001100: Rhinolast 140micrograms/dose nasal spray (Mawdsley-Brooks & Company Ltd) 20 ml (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Jul 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
60445901000001112 Rhinolast 140micrograms/dose nasal spray (Mawdsley-Brooks & Company Ltd) 20 ml (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
60446001000001115 Rhinolast 140micrograms/dose nasal spray (Mawdsley-Brooks & Company Ltd) 20 ml en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rhinolast 140micrograms/dose nasal spray (Mawdsley-Brooks & Company Ltd) 20 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Mawdsley-Brooks & Company Ltd) 20 ml Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Mawdsley-Brooks & Company Ltd) 20 ml Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Mawdsley-Brooks & Company Ltd) 20 ml Is a Azelastine 140micrograms/actuation nasal spray 20 ml true Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Mawdsley-Brooks & Company Ltd) 20 ml Has AMP Rhinolast 140micrograms/dose nasal spray (Mawdsley-Brooks & Company Ltd) true Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Mawdsley-Brooks & Company Ltd) 20 ml Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Mawdsley-Brooks & Company Ltd) 20 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Mawdsley-Brooks & Company Ltd) 20 ml VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Mawdsley-Brooks & Company Ltd) 20 ml Has specific active ingredient Azelastine hydrochloride true Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Mawdsley-Brooks & Company Ltd) 20 ml Has dispensed dose form Spray dose form true Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Mawdsley-Brooks & Company Ltd) 20 ml Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Mawdsley-Brooks & Company Ltd) 20 ml Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Mawdsley-Brooks & Company Ltd) 20 ml Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Mawdsley-Brooks & Company Ltd) 20 ml Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start